Special thanks to the following companies for supporting the 2014 Head and Neck Cancer Symposium with an unrestricted educational grant.




Multidisciplinary Head and Neck Cancer Symposium
February 20-22, 2014
JW Marriott Camelback Inn Resort and Spa, Scottsdale, Ariz.

Explore the multidisciplinary approach to head and neck cancer treatment as experts in the field covered novel molecular biologic therapies showing promise in improving outcomes, cutting-edge science, supportive care, directed therapy, updates on clinical trials, new treatment approaches, toxicity mitigation and new surgical and radiotherapeutic techniques.

NEW to this year's two-and-a-half day symposium were interactive, case-based discussion sessions that addressed either locally advanced or recurrent metastatic disease. Cases were able to be submitted on-site and for discussion by experts!

The 2016 Multidisciplinary Head and Neck Cancer Symposium will take place February 18-20, 2016, at the JW Marriott Camelback Inn Resort and Spa in Scottsdale, Ariz.

See what attendees from this year's 2014 Multidisciplinary Head and Neck Cancer Symposium said in their evaluation of the meeting:

  • "I thought this was a wonderful opportunity for academic and community physicians to come together and learn about head and neck cancer, which is increasing significantly in incidence, as well as the immense role that radiation plays in its treatment."
  • "As a very new member of the head and neck treatment team, the networking at this conference was invaluable and very validating. "
  • "Absolutely outstanding meeting that brings together the leaders in the field and cutting-edge basic science."
  • "Without a doubt the Multidisciplinary Head and Neck Symposium is the best blend of radiation oncologists, medical oncologists and head and neck surgeons, getting together in one place and working together to improve patient care."
  • "This conference provides the tools for practicing cancer specialists to offer patients the most modern and up-to-date treatments for their head and neck cancer. "